Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy
Study sponsor: AnaptysBio, Inc. · ANAB
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2018-03-30Actual
Enrollment · participants20Actual
Source updated2023-07-27Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.